Wednesday, January 30, 2013

• 4 Small Biotechs With Big Clinical Trials Presenting In 2013at Seeking Alpha (Wed, Jan 30)

Thursday, January 24, 2013

• Hospira Inks DealZacks (Thu, Jan 24)

Monday, January 7, 2013

• Advaxis to Present at the 6th Annual OneMedForumBusiness Wire (Mon, Jan 7)

Thursday, January 3, 2013

• Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development OfficerBusiness Wire (Thu, Jan 3)

Friday, December 28, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Fri, Dec 28)

Friday, December 21, 2012

• ADVAXIS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExhibitsEDGAR Online (Fri, Dec 21)

Thursday, December 13, 2012

• Advaxis Receives Preliminary Approval for Sale of Losses from State of NJ Economic Development AuthorityBusiness Wire (Thu, Dec 13)

Monday, December 10, 2012

• ADVAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Dec 10)

Monday, December 3, 2012

• Advaxis to Present at NYC MedTech ProgramBusiness Wire (Mon, Dec 3)

Monday, November 12, 2012

• Pennyland Biopharma Stocks: Value Or Value-Traps?at Seeking Alpha (Mon, Nov 12)

Wednesday, October 31, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements andEDGAR Online (Wed, Oct 31)

Thursday, October 18, 2012

• ADVAXIS, INC. Files SEC form 10-Q/A, Quarterly ReportEDGAR Online (Thu, Oct 18)

Tuesday, October 2, 2012

• ADVAXIS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Oct 2)
• ADVAXIS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Oct 2)

Thursday, September 27, 2012

• ADVAXIS, INC. FinancialsEDGAR Online Financials (Thu, Sep 27)

Friday, August 17, 2012

• ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or BylawsEDGAR Online (Fri, Aug 17)
• ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or BylawsEDGAR Online (Fri, Aug 17)

Monday, July 30, 2012

• Advaxis reports updated Phase 2 cervical cancer trial datatheflyonthewall.com (Mon, Jul 30)

Wednesday, July 25, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Wed, Jul 25)

Wednesday, July 11, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Wed, Jul 11)

Thursday, June 14, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Thu, Jun 14)

Friday, May 18, 2012

• ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial ObligatiEDGAR Online (Fri, May 18)

Monday, February 27, 2012

• Advaxis Reports Positive Phase II Trial ResultsZacks (Mon, Feb 27)

Add ADXS News to My Yahoo!